femal
infant
admit
neonat
icu
ankara
turkey
product
unremark
gestat
vagin
deliveri
week
began
symptom
upper
respiratori
infect
age
day
ill
abruptli
worsen
day
later
cough
cyanosi
period
apnea
progress
respiratori
failur
precipit
admiss
mother
receiv
dpt
diphtheria
pertussi
tetanu
vaccin
child
report
mild
cough
begin
week
prior
deliveri
upon
arriv
infant
apneic
episod
cyanosi
satur
drop
cough
spasm
initi
white
blood
cell
count
lymphocyt
chest
xray
reveal
infiltr
despit
ampicillin
gentamicin
deterior
endotrach
intub
necessari
discontinu
day
admiss
nasopharyng
wash
test
pcr
neg
respiratori
syncyti
viru
influenza
b
adenoviru
parainfluenza
viru
coronaviru
base
infant
symptom
complex
lymphocytosi
erythromycin
therapi
ad
day
nasopharyng
aspir
obtain
erythromycin
treatment
begun
posit
pertussi
pcr
cultur
agar
infant
serum
antibodi
pertussi
toxin
undetect
infant
slowli
improv
fewer
bout
paroxysm
cough
discharg
hospit
day
mother
contact
report
cough
contact
seroposit
pertussi
although
cultur
neg
emerg
infecti
diseas
shown
figur
center
diseas
control
prevent
cdc
discuss
section
frequenc
epidemiolog
number
report
case
pertussi
usa
part
develop
world
began
increas
first
decad
centuri
almost
case
report
highest
number
case
sinc
mani
infect
infant
requir
hospit
includ
least
death
outbreak
also
occur
europ
australia
japan
dramat
increas
appear
tie
introduct
safer
vaccin
pertussi
paradox
made
infect
emerg
actual
reemerg
diseas
highest
risk
signific
morbid
mortal
infant
primari
caus
pertussi
bordetella
pertussi
one
eight
speci
bordetella
genu
among
group
b
pertussi
b
parapertussi
b
bronchiseptica
studi
b
bronchiseptica
caus
kennel
cough
dog
asymptomat
carriag
occur
mani
anim
usual
human
pathogen
organ
appear
evolutionari
ancestor
b
pertussi
b
parapertussi
organ
highli
trophic
cilia
mucosa
respiratori
system
locat
signific
number
toxin
produc
particip
diseas
pathogenesi
b
pertussi
small
strictli
aerob
gramneg
coccobacillu
quit
fastidi
requir
specif
media
isol
morpholog
organ
distinguish
bordetella
haemophilu
speci
b
pertussi
nonmotil
oxidas
posit
catalas
posit
rel
inert
biochem
organ
isol
human
pertussi
whoop
cough
remain
commonli
report
vaccineprevent
diseas
unit
state
children
younger
year
pertussi
immun
part
dpt
vaccin
introduc
unit
state
late
seen
figur
number
report
case
drop
slowli
decad
period
bump
characterist
infect
nadir
case
number
lower
number
case
number
report
case
remain
low
rang
issu
reactogen
dpt
relat
whole
cell
pertussi
compon
becam
polit
issu
vaccin
inaccur
blame
perman
brain
damag
among
thing
pertussi
pediatr
immun
schedul
gradual
chang
acellular
one
vaccin
util
acellular
pertussi
toxoid
much
better
toler
seem
produc
similar
immun
respons
compar
dpt
unlik
dpt
vaccin
smaller
amount
pertussi
toxoid
tdap
could
toler
adult
accord
cdc
us
pertussi
rate
reach
case
highest
number
sinc
relat
death
accord
statist
cdc
adolesc
age
year
adult
togeth
account
pertussi
case
children
age
year
account
case
case
pertussi
report
cdc
incid
rate
pertussi
among
infant
exce
age
group
second
highest
rate
diseas
observ
among
children
year
old
rate
also
increas
adolesc
year
age
eighteen
pertussisrel
death
report
cdc
almost
death
occur
among
infant
younger
month
age
increas
pertussi
case
outbreak
report
major
state
fortynin
state
washington
dc
report
increas
diseas
compar
cdc
estim
case
pertussi
recogn
report
studi
adult
prolong
cough
found
pertussi
estim
worldwid
million
case
mortal
rate
nearli
death
per
year
casefat
rate
among
infant
lowincom
countri
may
high
pertussi
highli
contagi
respiratori
infect
particularli
household
set
inde
direct
inocul
organ
caus
diseas
suscept
children
review
attack
rate
unvaccin
children
household
set
rang
averag
much
lower
rang
classroom
contract
studi
clearli
transmiss
requir
repeat
prolong
exposur
close
contact
airborn
transmiss
via
respiratori
droplet
postul
clearli
proven
merkel
laboratori
demonstr
airborn
transmiss
infect
baboon
transmiss
infect
high
risk
infant
tend
occur
insid
famili
unit
australian
review
report
time
mother
sourc
father
grandpar
sibl
nonfamili
sourc
heterogen
rate
mani
circumst
sourc
identifi
dutch
review
estim
rel
infect
mother
father
report
korea
came
similar
conclus
clearli
mother
appear
major
player
neonat
transmiss
head
line
select
rather
univers
famili
cocoon
infant
use
even
entir
famili
vaccin
may
miss
potenti
exposur
contact
english
infant
age
week
nonhousehold
individu
last
minut
perhap
worst
scenario
nosocomi
transmiss
b
pertussi
neonat
nurseri
outbreak
prior
acellular
vaccin
use
introduc
symptomat
nurs
diagnos
infect
despit
characterist
ill
nurs
made
multipl
healthcar
visit
diseas
detect
prematur
infant
develop
pertussi
four
nurs
subsequ
diagnos
pertussi
probabl
transmit
nurs
prior
diagnosi
azithromycin
prophylaxi
recommend
infant
unit
time
ill
index
nurs
seventytwo
infant
receiv
postexposur
prophylaxi
pep
well
healthcar
worker
hcw
infant
case
occur
resid
physician
care
ill
infant
declin
prophylaxi
develop
pertussi
recent
outbreak
among
oncolog
nurs
also
show
transmiss
among
hcw
none
hcw
patient
avail
acellular
pertussi
vaccin
booster
hcw
especi
exposur
infant
vaccin
review
preston
de
gouw
et
al
hewlett
b
pertussi
produc
cadr
factor
involv
pathogenesi
major
adhes
factor
enabl
close
contact
organ
respiratori
epithelium
filament
hemagglutinin
fha
fimbria
pertactin
prn
fha
prn
includ
antigen
profil
acellular
vaccin
toxin
produc
organ
includ
g
pertussi
toxin
ptx
complex
hexamer
protein
adpribosyltransferas
g
adenyl
cyclas
toxin
act
posttransl
modifi
abl
facilit
apoptosi
cytotox
g
type
secret
system
effector
protein
btea
induc
rapid
nonapoptot
cell
death
g
tracheal
cytotox
tct
disaccharid
tetrapeptid
deriv
organ
cell
wall
caus
ciliostasi
damag
respiratori
epitheli
cell
ptx
major
part
form
acellular
pertussi
vaccin
felt
play
major
role
diseas
sine
qua
non
diseas
b
parapertussi
produc
similar
diseas
despit
produc
ptx
b
parapertussi
contain
gene
ptx
express
mutat
promot
gene
b
pertussi
contain
sever
regulatori
system
control
express
virul
gene
respons
environment
signal
notabl
bvgasr
organ
also
contain
sever
iron
acquisit
system
addit
vari
adher
toxic
factor
organ
success
persist
human
host
abil
interfer
almost
everi
aspect
immun
system
inhibit
complement
phagocytemedi
kill
suppress
tand
bcell
respons
understand
immun
system
modif
facilit
organ
may
assist
develop
effect
vaccin
pertussi
gener
incub
period
day
import
realiz
fifth
secondari
case
german
household
milieu
present
week
follow
primari
case
onset
may
reflect
longer
incub
period
exposur
later
primari
case
ill
review
cherri
heining
mattoo
cherri
mani
factor
impact
pertussi
ill
includ
age
previou
immun
statu
individu
size
inoculum
antimicrobi
therapi
presenc
passiv
acquir
specif
antibodi
genet
factor
host
organ
pertussi
acut
infect
respiratori
tract
classic
ill
frequent
occur
primari
infect
young
unimmun
children
clinic
cours
process
divid
three
stage
catarrh
phase
character
insidi
onset
mild
upper
respiratori
symptom
similar
rhinoviru
infect
includ
lowgrad
fever
coryza
sneez
mild
occasion
cough
week
stage
cough
gradual
becom
sever
paroxysm
phase
manifest
spasmod
cough
episod
paroxysm
mani
cough
without
inspir
spasm
sometim
follow
long
inspiratori
whoop
sound
andor
posttuss
vomit
paroxysm
attack
occur
frequent
night
may
precipit
eat
cyanosi
occur
paroxysm
spasmod
cough
may
mani
complic
includ
cerebr
hypoxia
subcutan
emphysema
subconjunctiv
hemorrhag
umbil
inguin
hernia
rib
fractur
sever
alkalosi
seizur
young
children
infant
may
appear
quit
distress
exhaust
follow
episod
remark
child
appear
well
attack
stage
usual
last
week
may
persist
week
neither
fever
pharyng
common
pertussi
unless
secondari
bacteri
superinfect
interven
third
convalesc
phase
recoveri
gradual
paroxysm
subsid
initi
frequenc
sever
cough
may
disappear
week
paroxysm
episod
may
return
respiratori
infect
import
awar
mild
even
asymptomat
infect
occur
especi
previous
immun
children
adolesc
adult
even
unimmun
children
mani
appar
healthi
infant
polymeras
chain
reaction
pcr
evid
pertussi
milder
ill
older
children
adolesc
adult
manifest
chronic
cough
last
week
longer
report
group
colleg
student
clinic
diagnos
pertussi
found
laboratori
evid
ill
mean
length
cough
week
two
featur
differenti
pertussi
nonpertussi
studi
nonproduct
cough
less
like
previou
use
antimicrobi
classic
pertussi
occur
adult
observ
adult
immunolog
prime
previou
infect
like
typic
pertussi
prime
immun
clearli
much
sever
morbid
almost
mortal
b
pertussi
infect
occur
younger
month
mani
infant
younger
month
age
pertussi
requir
hospit
cdc
report
infant
pertussi
pneumonia
seizur
encephalopathi
die
compar
parallel
number
infant
month
age
neonat
pertussi
observ
especi
sever
much
risk
death
symptom
substanti
differ
period
apnea
sometim
hypoxiainduc
seizur
usual
common
manifest
infect
cough
present
weak
may
unrecogn
children
socal
malign
pertussi
leukocytosi
particularli
white
blood
cell
wbc
count
sever
pulmonari
hypertens
omin
sign
mortal
studi
compar
neonat
pertussi
neonat
respiratori
infect
pertussisposit
neonat
longer
hospit
stay
less
fever
apnea
cyanosi
spell
requir
day
supplement
hospit
repres
infant
discharg
respiratori
support
care
proper
techniqu
obtain
specimen
cultur
pcr
found
http
wwwyoutubecomwatch
isol
b
pertussi
nasopharyng
specimen
pharyng
remain
gold
standard
diagnosi
cultur
specif
degre
sensit
modifi
length
ill
vaccin
statu
patient
age
highest
initi
catarrh
phase
isol
requir
special
transport
cultur
materi
agar
posit
requir
day
incub
pcr
b
pertussi
offer
higher
sensit
techniqu
standard
test
may
posit
bordetella
speci
result
obtain
within
day
assay
much
sensit
late
diseas
still
posit
nonviabl
organ
present
pcr
supplement
replac
cultur
direct
fluoresc
antigen
stain
avail
gener
recommend
diagnost
use
serolog
also
avail
antibodi
ptx
filament
hemagglutinin
also
avail
antipertussi
toxin
antiptx
may
take
week
becom
detect
antifha
help
distinguish
differ
bordetella
speci
neither
test
us
fda
approv
especi
earli
pertussi
ill
prior
earli
spasmod
cough
varieti
respiratori
virus
rhinoviru
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
influenza
may
confus
pertussi
specif
test
agent
along
pertussi
help
need
rememb
pertussi
coinfect
respiratori
viru
diagnos
respiratori
viru
exclud
possibl
pertussi
especi
popul
current
immun
acellular
vaccin
mild
pertussi
difficult
differenti
b
parapertussi
viral
bacteri
respiratori
infect
infect
b
parapertussi
caus
diseas
similar
pertussi
parapertussi
tend
milder
shorter
durat
pertussi
appear
area
scandinavia
two
infect
equal
frequenc
gener
diagnos
less
often
ratio
subclin
clinic
ill
much
higher
parapertussi
cultur
b
parapertussi
less
fastidi
oxidas
neg
urea
posit
produc
brown
pigment
heart
infus
agar
use
differ
primer
pcr
pertussi
parapertussi
differenti
although
present
b
bronchiseptica
serolog
parapertussi
express
ptx
ptx
antibodi
distinguish
ill
pertussi
parapertussi
antibodi
respons
fha
prn
similar
magnitud
b
holmesii
recent
describ
organ
initi
describ
caus
bacteremia
caus
symptom
complex
similar
b
pertussi
like
b
parapertussi
cocircul
popul
b
holmesii
contain
b
pertussi
produc
antipt
respons
appear
current
vaccin
adolesc
adult
affect
incid
b
parapertussi
b
holmesii
much
b
pertussi
increas
incid
widespread
commun
transmiss
pertussi
extens
contact
trace
broadscal
use
pep
among
contact
may
effect
use
limit
public
health
resourc
antimicrobi
agent
may
prevent
pertussi
given
prior
symptom
onset
data
indic
widespread
use
pep
among
contact
effect
control
limit
scope
pertussi
outbreak
use
pep
use
target
person
high
risk
develop
sever
pertussi
person
close
contact
high
risk
develop
sever
pertussi
cochran
review
look
trial
particip
trial
investig
treatment
two
trial
investig
prophylaxi
shortterm
macrolid
antimicrobi
use
azithromycin
day
clarithromycin
erythromycin
day
effect
long
term
erythromycin
day
erad
b
pertussi
nasopharynx
fewer
side
effect
trimethoprimsulfamethoxazol
day
also
effect
differ
clinic
outcom
microbiolog
relaps
shortand
longterm
antimicrobi
use
inde
therapi
effect
elimin
b
pertussi
patient
diseas
render
noninfecti
treatment
alter
subsequ
clinic
cours
ill
review
also
found
contact
prophylaxi
contact
older
month
age
antimicrobi
significantli
improv
clinic
symptom
number
case
develop
cultureposit
b
pertussi
rare
b
pertussi
found
resist
macrolid
resist
isol
report
usa
report
franc
also
document
resist
vaccin
primari
way
prevent
pertussi
previous
note
number
case
pertussi
industri
world
increas
wake
introduct
acellular
pertussi
vaccin
dtap
primari
immun
children
tdap
adult
small
letter
p
adult
vaccin
repres
lower
amount
immunogen
given
review
cherri
pertussi
reemerg
may
well
relat
increas
awar
diseas
chang
case
definit
increas
incid
nonpertussi
bordetella
greater
avail
pcr
diagnost
test
howev
sever
issu
exist
regard
rise
incid
pertussi
includ
lower
potenc
dtap
contribut
rapidli
wane
immun
potenti
genet
drift
strain
b
pertussi
clearli
current
formul
acellular
pertussi
vaccin
less
potent
whole
cell
ancestor
whether
measur
specif
antibodi
protein
vaccin
primari
sequenc
assess
pertussi
incid
sequenc
end
age
immun
pertussi
promptli
wane
inde
pertussi
incid
risk
ratio
rose
three
studi
state
high
time
time
minnesota
year
year
complet
sequenc
current
threeantigen
fiveantigen
compon
acellular
pertussi
vaccin
avail
usa
five
compon
vaccin
greater
efficaci
headtohead
comparison
interestingli
rel
risk
pertussi
time
higher
fivedos
ap
schedul
compar
receiv
least
one
dose
whole
cell
vaccin
six
dose
ap
rel
risk
compar
one
whole
cell
group
whether
chang
balanc
antigen
vaccin
ad
differ
antigen
unclear
respons
wane
immun
observ
follow
primari
immun
sequenc
acellular
pertussi
vaccin
immun
recommend
first
adolesc
adult
year
old
adult
year
older
final
order
best
cocoon
yet
unborn
babi
recommend
exist
ap
vaccin
pregnant
woman
trimest
evolut
chang
observ
b
pertussi
may
role
organ
abil
persist
highli
immun
popul
despit
genet
monomorph
natur
pathogen
without
horizont
acquisit
new
gene
mooi
colleagu
observ
strain
carri
mutat
gene
ptx
gene
promot
mediat
increas
product
associ
pertussi
resurg
genet
differ
surfac
protein
includ
ptx
prn
fimbria
addit
lan
australian
group
divid
b
pertussi
isol
six
cluster
base
singl
nucleotid
polymorph
snp
reemerg
pertussi
seem
coincid
emerg
snp
cluster
strain
carri
prn
ptx
gene
abl
evad
acellular
pertussi
vaccineinduc
select
pressur
like
wane
immun
relat
acellular
pertussi
vaccin
select
pressur
vaccin
work
tandem
better
recognit
ill
caus
pertussi
paradox
may
well
case
better
vaccin
may
need
control
resurg
better
protect
suscept
infant
